Weekly Roundup for JULY 8, 2022: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Understanding the Complex Relationship Between Infant Sleep and Maternal Sleep and Mental Health
Changes in maternal sleep and circadian rhythms during pregnancy are associated with infant sleep problems and maternal depression and anxiety.
Zuranolone for Postpartum Depression: Results from the SKYLARK Study
Zuranolone has antidepressant effects in women with severe PPD, observed as early as 3 days after initiation of treatment. Â
Pregnant Women with Depression: Greater Use of Cannabis and Benzodiazepines, But Not Antidepressants
Cannabis use, as well as use of benzodiazepines and sedative-hypnotic medications, was more common in women with depression.
Relapse of Bipolar Disorder During Pregnancy Increases Risk of Postpartum Illness
More that half of women with bipolar disorder relapsed during pregnancy.
Essential Reads: The Pregnancy and Lactation Labeling Rule (PLLR)
The PLLR helps to put the potential effects of the drug into perspective with the goal of providing a more individualized risk-benefit analysis.
Neurodevelopmental Disorders in Children Exposed to Antipsychotic Medications During Pregnancy
Prenatal exposure to antipsychotic medications was not associated with increased risk of neurodevelopmental disorders in offspring.
Weekly Roundup for APRIL 1, 2022: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Knowns and Unknowns About SSRI Use During Pregnancy in 2022
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on clinical issues regarding prescribing antidepressants during pregnancy with Ob.Gyn News on March 23, [...]
Lower Risk of Self-Harm During Pregnancy, Except in Younger Women
Lower risk for self-harm was observed during pregnancy, except in women aged 15 to 19 years.